3 Broker Favorite Biopharmas Your Portfolio Must Have Post author:Sam Post published:January 17, 2018 Post category:BioPharma These stocks have been given a Strong Buy or Buy rating by 80% or more brokers. Source: BioSpace You Might Also Like Eleven Bio To Report Second Quarter 2017 Financial Results On Monday, August 14, 2017 August 6, 2017 Novartis AG's Phase III Drug for Heart Failure Bombs Trial March 21, 2017 Germany's Novaliq Sets Up U.S. Subsidiary in Cambridge, Massachusetts January 8, 2018
